Oxpay Financial Ltd
SGX:TVV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oxpay Financial Ltd
SGX:TVV
|
SG |
|
M
|
Maha Rashtra Apex Corporation Ltd
BSE:523384
|
IN |
|
T&K Toka Co Ltd
TSE:4636
|
JP |
|
Sriwahana Adityakarta Tbk PT
IDX:SWAT
|
ID |
|
Septeni Holdings Co Ltd
TSE:4293
|
JP |
|
Bouygues SA
OTC:BOUYY
|
FR |
|
S
|
S2Medical AB (publ)
STO:S2M
|
SE |
|
Vidhi Specialty Food Ingredients Ltd
NSE:VIDHIING
|
IN |
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
S
|
Scotgold Resources Ltd
LSE:SGZ
|
AU |
|
J
|
Jaykay Enterprises Ltd
BSE:500306
|
IN |
Income Statement
Earnings Waterfall
Oxpay Financial Ltd
Income Statement
Oxpay Financial Ltd
| Mar-2020 | Sep-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
18
+199%
|
18
+1%
|
10
-44%
|
11
+9%
|
8
-22%
|
3
-60%
|
4
+9%
|
4
+13%
|
5
+28%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
(3)
|
(7)
|
(8)
|
(7)
|
(8)
|
(6)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
10
+267%
|
9
-11%
|
3
-72%
|
2
-12%
|
2
+9%
|
2
-4%
|
2
-2%
|
2
-2%
|
3
+28%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(6)
|
(11)
|
(5)
|
(3)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(6)
|
(11)
|
(5)
|
(3)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(1)
N/A
|
(1)
-23%
|
(1)
+47%
|
(3)
-496%
|
(1)
+79%
|
4
N/A
|
(1)
N/A
|
(3)
-519%
|
(3)
+14%
|
(3)
-2%
|
(3)
-12%
|
(3)
-2%
|
(4)
-20%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
1
|
0
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(26)
|
(26)
|
0
|
0
|
(0)
|
1
|
1
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(2)
-41%
|
(1)
+45%
|
(31)
-2 303%
|
(27)
+11%
|
4
N/A
|
(0)
N/A
|
(3)
-574%
|
(1)
+51%
|
(2)
-35%
|
(3)
-66%
|
(3)
-5%
|
(4)
-21%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(2)
|
(1)
|
(31)
|
(27)
|
4
|
(0)
|
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(2)
-41%
|
(1)
+45%
|
(31)
-2 297%
|
(27)
+12%
|
4
N/A
|
(0)
N/A
|
(3)
-512%
|
(1)
+53%
|
(2)
-34%
|
(3)
-68%
|
(3)
-5%
|
(4)
-21%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.07
-40%
|
-0.04
+43%
|
-0.12
-200%
|
-0.12
N/A
|
0.02
N/A
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|